Influenza Antiviral Prescribing for Outpatients with an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications during 5 Influenza Seasons-United States, 2011-2016

Clinical Infectious Diseases

Volumn 66, Issue 7, 2018, Pages 1035-1041

  Stewart, Rebekah J ^a,b   Flannery, Brendan ^b   Chung, Jessie R ^b   Gaglani, Manjusha ^c   Reis, Michael ^c   Zimmerman, Richard K ^d   Nowalk, Mary Patricia ^d   Jackson, Lisa ^e   Jackson, Michael L ^e   Monto, Arnold S ^f   Martin, Emily T ^f   Belongia, Edward A ^g   McLean, Huong Q ^g   Fry, Alicia M ^b   Havers, Fiona P ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c TEXAS A M COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e GROUP HEALTH RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^g MARSHFIELD CLINIC   (United States)

Author keywords

Antiviral treatment; Influenza; Neuraminidase inhibitors; Outpatient

Indexed keywords

INFLUENZA VACCINE; ANTIVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; ELECTRONIC MEDICAL RECORD; FEMALE; FEVER; HIGH RISK PATIENT; HUMAN; INFLUENZA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNITED STATES; ACUTE DISEASE; COMPLICATION; INFANT; MIDDLE AGED; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; RISK FACTOR; SEASON; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG PRESCRIPTIONS; FEMALE; HUMANS; INFANT; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OUTPATIENTS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SEASONS; UNITED STATES; YOUNG ADULT;

EID: 85044211257     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix922     Document Type: Article

References (21)

1. Reed C, Chaves SS, Daily Kirley P, et al. Estimating influenza disease burden from population-based surveillance data in the United States. PLoS One 2015; 10:e0118369.
2. Fowlkes A, Dasgupta S, Chao E, et al. Estimating influenza incidence and rates of influenza-like illness in the outpatient setting. Influenza Other Respir Viruses 2013; 7:694-700.
3. Fowlkes A, Steffens A, Temte J, et al; Influenza Incidence Surveillance Project Working Group. Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13. Lancet Respir Med 2015; 3:709-18.
4. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM; Centers for Disease Control and Prevention (CDC). Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60:1-24.
5. Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 2015; 385:1729-37.
6. Hernán MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials. Clin Infect Dis 2011; 53:277-9.
7. Biggerstaff M, Jhung M, Kamimoto L, Balluz L, Finelli L. Self-reported influenza-like illness and receipt of influenza antiviral drugs during the 2009 pandemic, United States, 2009-2010. Am J Public Health 2012; 102:e21-6.
8. Biggerstaff M, Jhung MA, Reed C, Fry AM, Balluz L, Finelli L. Influenza-like illness, the time to seek healthcare, and influenza antiviral receipt during the 2010-2011 influenza season-United States. J Infect Dis 2014; 210:535-44.
9. Havers F, Flannery B, Clippard JR, et al. Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season. Clin Infect Dis 2015; 60:1677-80.
10. Havers F, Thaker S, Clippard JR, et al. Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season. Clin Infect Dis 2014; 59:774-82.
11. Lee N, Chan PK, Choi KW, et al. Factors associated with early hospital discharge of adult influenza patients. Antivir Ther 2007; 12:501-8.
12. Lee N, Choi KW, Chan PK, et al. Outcomes of adults hospitalised with severe influenza. Thorax 2010; 65:510-5.
13. Yu H, Liao Q, Yuan Y, et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 2010; 341:c4779.
14. Chou R, Dana T, Blazina I, et al. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Statin use for the prevention of cardiovascular disease in adults: a systematic review for the US Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality, 2016.
15. deLeeuw J. Introduction to Akaike (1973) information theory and an extension of the maximum likelihood principle. In: Kotz S, Johnson NL, eds. Breakthroughs in statistics. New York: Springer, 1992.
16. Fowlkes A, Giorgi A, Erdman D, et al. Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the Influenza Incidence Surveillance Project, 2010-2011. J Infect Dis 2014; 209:1715-25.
17. Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. Available at: https://www.cdc.gov/flu/professionals/antivirals/ summary-clinicians.htm. Accessed 10 February 2017.
18. Rothberg MB, Bonner AB, Rajab MH, Kim HS, Stechenberg BW, Rose DN. Effects of local variation, specialty, and beliefs on antiviral prescribing for influenza. Clin Infect Dis 2006; 42:95-9.
19. Williams LO, Kupka NJ, Schmaltz SP, Barrett S, Uyeki TM, Jernigan DB. Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings preand post-2009 H1N1 pandemic. J Clin Virol 2014; 60:27-33.
20. Centers for Disease Control and Prevention. Medical office telephone evaluation of patients with possible influenza. Available at: https://www.cdc.gov/flu/professionals/ antivirals/office-evaluation.htm. Accessed 10 February 2017.
21. American Academy of Pediatrics. Recommendations for prevention and control of influenza in children, 2016-2017. Pediatrics 2016; 138(4):e20162527.